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Metabolosomes, catabolic bacterial microcompartments, are proteinaceous organelles that 2 
are associated with the breakdown of metabolites such as propanediol and ethanolamine. 3 
They are composed of an outer multi-component protein shell that encases a specific 4 
metabolic pathway. Protein cargo found within BMCs is directed by the presence of an 5 
encapsulation peptide that appears to trigger aggregation prior to the formation of the outer 6 
shell. We investigated the effect of three distinct encapsulation peptides on foreign cargo in a 7 
recombinant BMC system. Our data demonstrate that these peptides cause variation with 8 
respect to enzyme activity and protein aggregation. We observed that the level of protein 9 
aggregation generally correlates with the size of metabolosomes, while in the absence of 10 
cargo BMCs self-assemble into smaller compartments. The results agree with a flexible model 11 
for BMC formation based around the ability of the BMC shell to associate with an aggregate 12 
formed due to the interaction of encapsulation peptides.  13 
 3 
Introduction 14 
Bacterial microcompartments (BMCs) are proteinaceous organelles found within a broad 15 
range of bacteria (Axen et al., 2014, Bobik et al., 2015, Kerfeld et al., 2018). They consist of 16 
an outer semi-permeable protein shell that surrounds and sequesters a specific metabolic 17 
process. BMCs have a diameter of between 100-200 nm and can be broadly classified into 18 
two main groups on the basis of whether they promote anabolic or catabolic processes. 19 
Anabolic BMCs are associated with carbon fixation and house enzymes such as RuBisCO 20 
and carbonic anhydrase and are termed carboxysomes (Kerfeld et al., 2010, Rae et al., 2013, 21 
Yeates et al., 2008). Catabolic BMCs are associated with the breakdown of metabolites such 22 
as propanediol, ethanolamine and choline, compounds often found in the gut mucosa (Bobik, 23 
2006, Bobik et al., 1999, Cheng et al., 2008, Kerfeld et al., 2018). These degradative BMCs 24 
are referred to as metabolosomes (Brinsmade et al., 2005). In all cases studied so far, 25 
metabolosomes appear to produce an aldehyde intermediate that is then converted into its 26 
alcohol and acid derivatives. The need to encapsulate such metabolic processes appears to 27 
protect the cell from potentially toxic intermediates and at the same time promotes metabolic 28 
flux (Jakobson et al., 2017, Penrod & Roth, 2006, Sampson & Bobik, 2008). 29 
BMCs are composed of a number of different shell proteins that form either homogeneous 30 
hexameric or pentameric tiles, which link together to form the facets and vertices of the 31 
macromolecular structure respectively (Kerfeld et al., 2005, Tanaka et al., 2008). The structure 32 
of a small hollow recombinant BMC shell has recently been reported, providing strong 33 
evidence on the orientation of the tiles and how they associate to give the overall assembly 34 
(Sutter et al., 2017). The shell protein tiles have a central pore that is thought to allow 35 
metabolites and cofactors into and out of the complex, possibly through a gated mechanism. 36 
Many of the metabolic cargo enzymes that are found within the lumen of the BMC are known 37 
to contain an N-terminal, or less frequently a C-terminal, encapsulation peptide that is around 38 
18-20 amino acids in length, and which forms an amphipathic helix (Aussignargues et al., 39 
2015, Fan & Bobik, 2011, Fan et al., 2010, Lawrence et al., 2014, Kinney et al., 2012). For 40 
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metabolosomes, studies have shown that the N-terminal 18 amino acids of PduD (D18) (Fan 41 
& Bobik, 2011) and PduP (P18) (Fan et al., 2010), as well as the first twenty amino acids of 42 
PduL (L20) (Liu et al., 2015), can act as targeting peptides that can direct foreign cargo, such 43 
as fluorescent proteins, to the BMC. 44 
Research into the biogenesis of BMCs has largely focussed on the carboxysomes, which 45 
generally form larger and more symmetrical icosahedral structures than the metabolosomes 46 
(Kerfeld & Melnicki, 2016, Iancu et al., 2007). Two types of carboxysomes are known, with the 47 
β-carboxysome structural proteins sharing high homology with catabolic BMC proteins. 48 
Imaging has shown that the protein shell of β-carboxysomes is able to form around an 49 
aggregate of the protein cargo, with the size and shape of the BMC defined by the architecture 50 
of the shell proteins (Cameron et al., 2013, Chen et al., 2013). This core-first assembly 51 
involves the formation of an initial aggregate that gains its shape from the interaction of the 52 
shell proteins, which as it closes pinches off the excess aggregate, allowing it to form another 53 
BMC. A different assembly process occurs within the -carboxysome, where some key 54 
proteins help in this fabrication process, including CsoS2 (Cai et al., 2015). This concomitant 55 
folding involves the assembly of shell and core proteins together with the chaperoning of core 56 
proteins. However, the mechanisms of BMC formation are likely not universal. Metabolosomes 57 
are much more irregular in both their size and shape in comparison to carboxysomes. 58 
Furthermore, through the recombinant production of BMC shell proteins derived from the 59 
propanediol utilisation system it has been shown that the shell proteins can self-assemble into 60 
a smaller BMC in the absence of any protein cargo (Parsons et al., 2010, Mayer et al., 2016). 61 
Thus, shell proteins have the ability to self-assemble into empty structures. 62 
BMCs represent powerful metabolic units in the form of small bioreactors and as such they 63 
have caught the attention of metabolic engineers who see these organelles as a way to 64 
redesign specific aspects of cellular metabolism for the production of fine and commodity 65 
chemicals (Frank et al., 2013, Kim & Tullman-Ercek, 2013, Lawrence et al., 2014, Lee et al., 66 
2018b, Liang et al., 2017, Mayer et al., 2016). Key to the redesign of BMCs with alternative 67 
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metabolic functions is the ability to encapsulate new pathways into the structures. Evidence 68 
that BMCs can be reengineered has come from a proof-of-principle study whereby a pyruvate 69 
decarboxylase (PDC) and an alcohol dehydrogenase were directed to an empty BMC through 70 
the addition of encapsulation peptides (Lawrence et al., 2014). The resulting BMC was found 71 
to have the ability to convert pyruvate into ethanol. 72 
Although a broad range of potential encapsulation peptides have been identified, comparative 73 
studies on their ability to direct cargo to BMCs have been limited. Screens to report improved 74 
changes to the encapsulation peptide have been reported but these are based on the use of 75 
fluorescent proteins and their localisation to puncta in cells by fluorescent microscopy (Kim & 76 
Tullman‐Ercek, 2014). However, as encapsulation peptides promote aggregation, which can 77 
be visualised also as fluorescent foci, the use of fluorescent puncta as a means to judge 78 
localisation does not differentiate between protein aggregation and BMC encapsulation (Lee 79 
et al., 2018b). 80 
Herein, we describe research that was undertaken to develop improved methods to quantitate 81 
the incorporation of cargo into BMCs. Initially, the ability of the Citrobacter freundii PduD, PduL 82 
and PduP to direct cargo to an empty recombinant C. freundii Pdu BMC was investigated. 83 
Thereafter, the C. freundii D18, L20 and P18 tags were investigated for their effect on the 84 
activity of a range of PDCs in order to inform on the choice of tag. The peptides were also 85 
studied for their ability to co-aggregate different proteins in vivo. We demonstrate that 86 
metallothionein can be used to follow aggregation and encapsulation as it is easily identifiable 87 
by TEM due to its increased electron density, which is most likely caused by its metal binding 88 
capacity. Finally, we present electron tomography studies of empty recombinant C. freundii 89 
Pdu BMCs and metallothionein targeted to these BMCs. Collectively, this work demonstrates 90 
a correlation between cargo-protein aggregation, the level of assimilation into BMCs and their 91 





Targeting of native enzymes into recombinant Pdu BMCs 96 
In order to understand the relative abilities of the encapsulation peptides found on C. freundii 97 
PduD (Fan & Bobik, 2011), PduL (Liu et al., 2015) and PduP (Fan et al., 2010) to mediate 98 
cargo encapsulation into a recombinant C. freundii Pdu BMC, we first sought to look at how 99 
well these proteins were integrated into an empty BMC. We therefore individually produced 100 
PduD, PduL and PduP in the presence and absence of empty Pdu BMCs (PduA-U) (Parsons 101 
et al., 2010). When these BMC-associated enzymes were produced in the absence of 102 
compartments, large inclusion bodies were observed in a high proportion of cells (PduD: 103 
55.8%; PduL: 67.0%; PduP 71.7%; Figure A1 (Appendix 1)) with no such structures present 104 
in an empty vector control strain (Figure 1). This observation is consistent with the prediction 105 
that these proteins self-aggregate. 106 
Co-production of PduD or PduL with PduA-U resulted in a decrease in the observed 107 
aggregation (Figure 1 and Figure A1 (Appendix 1)). The inclusions observed in these cells 108 
were phenotypic of misfolded BMC shell proteins (Figure A2 (Appendix 1)), suggesting that 109 
the majority of PduD and PduL were encapsulated. However, co-production of PduP with 110 
BMCs only showed a slight decrease in the percentage of cells containing inclusion bodies 111 
(Figure A1 (Appendix 1)), although a high proportion of cells (58.1%) still contained 112 
inclusions, suggesting lower encapsulation efficiency or greater aggregation rate. Electron 113 
microscopy analysis was also carried out on purified BMCs from these strains (Figure 1). 114 
Areas of darker staining within the isolated BMCs indicate that the BMCs contain protein cargo 115 
and thus the number of BMCs containing darker staining can be used to gauge targeting to 116 
the lumen of intact microcompartments (Figure A3 (Appendix 1)). Darker electron density 117 
within the BMC is therefore indicative of protein encapsulation. These BMCs were compared 118 
to BMCs produced in the absence of cargo. Electron dense regions were observed in the 119 
lumen of BMCs isolated from the strains producing PduD, PduL or PduP, suggesting that all 120 
three proteins are incorporated into the recombinant BMCs. The efficiency of protein 121 
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incorporation displayed a degree of variation with both PduP and PduD showing a higher level 122 
of assimilation in comparison to PduL. 123 
 124 
Effect of Pdu BMC encapsulation tags on three different pyruvate decarboxylases 125 
Previously, we reported the effect of encapsulation tags on the activity of pathway enzymes 126 
associated with propanediol synthesis (Lee et al., 2016). Herein, we investigated the effect of 127 
different encapsulation peptides on the activity of PDC, an enzyme we had previously shown 128 
could be targeted to a recombinant BMC (Lawrence et al., 2014), and explored if the effects 129 
were identical on three homologous PDCs. The selected PDCs have a high level of protein 130 
sequence similarity (Figure A4 (Appendix 1)) as this would allow us to determine if the 131 
addition of encapsulation peptides have a reproducible effect on enzymatic activity.  132 
In order to undertake this comparison we looked at the effect on enzyme activity after fusing 133 
three different BMC encapsulation peptides (D18, L20 and P18) onto PDCs from 134 
Gluconacetobacter diazotrophicus (GdPDC), Zymomonas mobilis (ZmPDC) and Zymobacter 135 
palmae (ZpPDC). The encapsulation peptides were fused to the N-terminus of the PDCs 136 
together with a hexa-histidine linker and a thrombin cleavage site. The control construct 137 
contained only a PDC with a hexa-histidine linker and a thrombin cleavage site. The activities 138 
of the purified tagged (D18, L20, P18) and untagged enzymes were followed in a linked assay.  139 
A comparison of the activities is shown in Figure 2. 140 
The data show that despite a high level of sequence similarity between the enzymes (Figure 141 
A4 (Appendix 1)), particularly at the N-terminus where the encapsulation peptide is located, 142 
the different tags have a variable effect on activity. For instance, in comparison to the His-only 143 
control, the different tags did not greatly affect GdPDC activity, whereas the Vmax of ZpPDC 144 
was reduced by around 50% when the protein was tagged with a D18 or P18 encapsulation 145 
peptide. Overall, the L20 tag was found to have the least disruptive effect on the activity of the 146 
enzymes. The activity results suggest that the effect of the encapsulation tags is not 147 
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dependent on sequence similarity, making it difficult to predict the behaviour of a tagged 148 
enzyme. 149 
A comparative analysis of encapsulation efficiencies 150 
Although mutagenesis approaches to improving the ability of encapsulation peptides to 151 
promote assimilation have been reported (Kim & Tullman‐Ercek, 2014), no direct comparison 152 
has been undertaken to determine the relative targeting efficiencies of the various 153 
encapsulation peptides that have been used to direct non-natural cargo to recombinant BMCs. 154 
However, knowledge on the relative effectiveness of the different peptides would be a key 155 
facilitator of BMC technology in an industrial setting. 156 
To investigate the encapsulation efficiencies of the D18, L20 and P18 encapsulation peptides 157 
we utilised a combination of confocal fluorescence microscopy and immuno-TEM. A yellow 158 
fluorescent protein (Citrine) was fused to the D18, L20 and P18 tags. The genetic constructs 159 
for these fused proteins were co-expressed with either recombinant BMCs containing an 160 
mCherry fused PduA (mA-U) (Parsons et al., 2010) or an empty vector control (pLysS) and 161 
analysed (Figure 3). 162 
Expression of either D18 or P18 tagged Citrine, in the absence of BMCs, resulted in the 163 
appearance of inclusion bodies, which were visible by both microscopy methods.  In contrast, 164 
the L20 tagged protein appeared more soluble, but was observed to localise to the periphery 165 
of the cell. Analysis of a strain producing only mA-U revealed the presence of red puncta within 166 
the cytoplasm, an observation that has been attributed to the formation of BMCs within the 167 
cell (Parsons et al., 2010). When co-produced with mA-U, both D18- and P18-tagged Citrine 168 
localised to these red punctate regions, which is indicative of co-localisation with BMCs. 169 
In contrast, the L20-tagged protein did not appear to target specifically to the punctate regions 170 
of the cells, although there was a change in the observed phenotype with the signal more 171 
evenly dispersed throughout the cell. Quantification of the inclusion bodies present in these 172 
strains by TEM (Figure A5 (Appendix 1)) did not show a reduction when co-produced with 173 
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BMCs as has been observed previously with the full-length PduD, PduL and PduP proteins 174 
(Figure A1 (Appendix 1)). The difference may be explained by the modification of PduA in 175 
the mA-U construct as the addition of the mCherry label to PduA may alter BMC stability or 176 
result in increased shell protein aggregation.  177 
Co-aggregation of tagged proteins 178 
It would appear that the presence of D18 and P18 on proteins aids in the formation of cellular 179 
inclusion bodies. Previous work had also shown that the expression of 4 proteins involved in 180 
a 1,2-propanediol synthesis pathway tagged with encapsulation peptides results in the 181 
formation of a single large inclusion body, which is thought to contain all of the tagged 182 
components (Lee et al., 2016). To investigate this aggregation phenotype more thoroughly we 183 
co-produced two fluorescent proteins (mCherry and Citrine) containing the various Pdu 184 
targeting tags to see if the fluorescent signals localise to the same region of the cell and form 185 
puncta indicative of protein aggregation (Figure 4). 186 
Co-expression of His-mCherry with His-Citrine resulted in dispersed fluorescence throughout 187 
the cytoplasm (Figure A6 (Appendix 1)). However, the introduction of either a D18 or P18 188 
tag onto the N-terminus of mCherry resulted in its aggregation (Figures A7 and A8 (Appendix 189 
1)), whilst the His-Citrine fluorescent signal remained cytoplasmic. In contrast, the production 190 
of L20-mCherry resulted in mostly cytoplasmic fluorescence suggesting that this targeting 191 
peptide has a lower predisposition for aggregation (Figure A9 (Appendix 1))  192 
When the fluorescent proteins were tagged with either the D18 or P18 encapsulation peptides 193 
co-aggregation was observed, demonstrating that the tagged components are aggregated into 194 
a single inclusion body rather than separate bodies (Figure 4). Again, the L20 tagged 195 
fluorescent proteins appeared much more soluble than their P18 or D18 equivalents, although 196 
when the L20-fluorescent proteins were co-produced together with a different fluorescent 197 
protein tagged with either a D18 or P18 tag, the fluorescent signals appeared to co-localise 198 
with the punctate aggregates (Figure 4 and Figure A9 (Appendix 1)). Thus it would appear 199 
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that whilst the L20 encapsulation peptide is more soluble it interacts with D18- and P18-tags 200 
leading to co-aggregation. 201 
Targeting metallothionein to recombinant Pdu BMCs 202 
In order to study further the efficiency of targeting recombinant proteins into BMCs we utilised 203 
a metal binding protein, metallothionein, due to its propensity to bind a variety of metal ions 204 
(Kagi & Schaffer, 1988) making it comparatively easy to visualise within the cell by TEM when 205 
aggregated. The idea behind the metallothionein approach is that it should allow the 206 
opportunity to observe encapsulated aggregates in whole cell sections as opposed to relying 207 
on in vitro data obtained from purified compartments, allowing a comparison of their relative 208 
size, shape and volume. We therefore tagged a metallothionein from Fucus vesiculosus 209 
(Morris et al., 1999) (fvMT) with the three different encapsulation peptides as well as a His-tag 210 
control. These constructs were co-produced with PduA-U and the resulting strains, as well as 211 
purified BMCs, were analysed by TEM (Figure 5). As expected, the use of fvMT did indeed 212 
allow the protein aggregates to be easily identified by TEM due to the increased electron 213 
density. Thin sections of cells from strains producing only the His-fvMT, D18-fvMT, L20-fvMT 214 
and P18-fvMT all showed the presence of a large aggregate in the absence of BMCs. When 215 
this was repeated with strains producing not only the tagged fvMT but also empty 216 
compartments (PduA-U), smaller bodies with sharp edges were observed, which is indicative 217 
of encapsulation into a BMC. 218 
Quantification indicated that the presence of either the D18 or L20 peptides on the fvMT 219 
resulted in efficient encapsulation (99.3% and 96.1% respectively; Figure A10 (Appendix 1)), 220 
in that the vast majority fvMT was found associated with BMC rather than an inclusion body. 221 
By way of contrast, the P18 tagged fvMT shows only roughly half that level (54.0%) with an 222 
even distribution between aggregates and BMCs. The presence of an encapsulation peptide 223 
resulted in an overall decrease in the presence of non-encapsulated aggregation with the D18-224 
tag proving to be the most effective (Figure A11 (Appendix 1)). We also observed a high 225 
proportion of empty BMCs present in the cells (Figure 5, third row), suggesting that the ratio 226 
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of cargo to shell production in a recombinant system requires further optimisation. 227 
Significantly, the BMCs observed with the tagged-fvMT all appear much larger than the BMCs 228 
isolated from the untagged fvMT. To demonstrate that the angular electron-dense bodies are 229 
BMCs the thin sections of the various strains were analysed by immuno-TEM using an anti-230 
PduA antibody (Figure A12 (Appendix 1)). If the angular structures are BMCs then we would 231 
expect them to cross-react with the anti-PduA antibody, is what was observed and consistent 232 
with these aggregates being surrounded by a BMC shell. 233 
The purified compartments produced in these various strains were also analysed by TEM 234 
(Figure 5 and Figure A12 (Appendix 1)). Significantly, the BMCs co-produced with His-fvMT 235 
did not appear to have any cargo present after purification. The BMCs isolated from strains 236 
with the fvMT-tagged with the encapsulation peptides had various observed incorporation 237 
efficiencies (D18 – 24.7%; L20 – 16.5%; P18 – 30.5%). The purified BMCs co-produced with 238 
P18-fvMT also contained what appeared to be large inclusion bodies (Figure A13 (Appendix 239 
1)). We suggest that these are large P18-fvMT inclusions that co-purify non-specifically with 240 
the compartments. Inclusion bodies like these are likely to pull down during BMC purification 241 
due to their large size, highlighting the importance of using TEM for this analysis as well in 242 
addition to standard western blot analysis to define encapsulation of proteins into BMCs. 243 
The fvMT-producing strains were further analysed by electron tomography in order to gain a 244 
better visualisation of the three-dimensional topography of these structures (Figure 5 and 245 
Supplementary Video 1). This approach revealed the structures formed by fvMT and BMC 246 
shell proteins are remarkably varied in size, shape and volume. Furthermore, AMIRA software 247 
was used to gather quantitative data analysing enclosed structures in these tomograms 248 
(Weber et al., 2012). This approach allowed us to gain further insight into the 3D structure 249 
(Figure 6) of empty recombinant BMCs (Supplementary Video 2) and recombinant BMCs 250 
containing L20-fvMT (Supplementary Video 3) allowing us to quantitate the volume (empty: 251 
54900±11013 nm3 (n=29); L20-fvMT: 336411±177722 nm3 (n=60)) and the largest diameter 252 
(empty: 61.77±15.38 nm (n=29); L20-fvMT: 127.51±60.97 nm (n=60)) of these structures. This 253 
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data suggests an average volumetric expansion of around 6 times to accommodate L20 254 
targeted fvMT. Modelling suggests that strong cargo-cargo interactions lead to an increase in 255 
compartment size, while strong shell-shell interactions lead to smaller, better defined 256 
structures (Mohajerani & Hagan, 2018, Perlmutter et al., 2016). Our observations therefore 257 
are indicative of an assembly mechanism dominated by strong cargo-cargo interactions. 258 
These findings could also explain the previously observed variability in BMC size and shape 259 
(Mayer et al., 2016). 260 
Discussion  261 
It had previously been observed that the removal of the N-terminal extension found on some 262 
of the diol dehydratases linked with BMC-catabolic processes improved their solubility, 263 
allowing for their structure determination (Fan et al., 2010). Studies on the structure of the P18 264 
peptide revealed that it forms an amphipathic helix that encourages self-association through 265 
a coiled-coil interaction (Lawrence et al., 2014). In this way the encapsulation peptides 266 
promote protein aggregation. The protein aggregate must then be able to interact with the 267 
luminal side of the BMC shell. Indeed, the identification of P18 as an encapsulation peptide 268 
also led to suggestions that the peptide may interact with one particular component of the 269 
shell, PduA. Specifically, modelling studies suggested that the P18 peptide could interact with 270 
a helical region of PduA (Fan et al., 2012). However, this region of PduA is on the concave 271 
side of the PduA hexamer. If the recent structure determination of a recombinant BMC from 272 
Haliangium ochraceum (Sutter et al., 2017) is an accurate representation of a wild type 273 
compartment, and all the shell proteins have their concave side facing into the cytoplasm, then 274 
this encapsulation model will need to be modified to explain how the cargo protein becomes 275 
localised within the lumen. 276 
By studying the production of PduD, PduL and PduP in the presence and absence of BMCs 277 
we have shown that, individually, PduD, PduL and PduP all form aggregates in the cell. 278 
However, in the presence of BMCs the majority of PduD and PduL become incorporated into 279 
the BMCs, as viewed by higher electron density within isolated BMCs and the reduction in the 280 
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observable intracellular aggregation. High levels of intracellular aggregation were still 281 
observed for PduP, although targeting was confirmed within BMCs. Using TEM for 282 
investigation of higher density within the BMCs represents an important technique to help in 283 
the validation that protein cargo is being localised within the BMC. This can be used to help 284 
support evaluation of localisation with fluorescent proteins and the presence of fluorescence 285 
puncta within cells. 286 
It was interesting to observe the effect of the addition of encapsulation peptides to a range of 287 
PDCs from different organisms. We thought that there may be some common effects of these 288 
encapsulation peptides on the activities of the homologous enzymes. For instance, we would 289 
have predicted that L20 would have less of an effect on activity than the other tags. In fact, we 290 
could not observe any specific trend with the peptide. The tags had little to no effect on the 291 
activity of the PDC from G. diazotrophicus, whereas the P18 and D18 tags had a clear effect 292 
on the Z. palmae PDC. This means that predicting the effect of the addition of a targeting 293 
peptide to an enzyme is likely to be very challenging. 294 
Attachment of the encapsulation peptides to fluorescent proteins allowed for a study of their 295 
co-localisation in the absence of BMCs. The work shows that fluorescent proteins containing 296 
targeting tags can co-aggregate together prior to encapsulation. These results suggest a 297 
possible assembly mechanism where cargo proteins co-aggregate together prior to 298 
encapsulation. 299 
To gauge the effect of targeting to BMCs, one really needs to be able to see if protein has 300 
been internalised within the structure and also to be able to measure the size and shape of 301 
the compartment. We were able to achieve this through the use of metallothionein where 302 
aggregated protein is easily identifiable within the cell due to its extra density caused by the 303 
acquisition of metal ions. Using fvMT we were able to demonstrate that all the encapsulation 304 
tags, when attached to the protein, cause encapsulation within recombinant BMCs. These 305 
studies are all consistent with a model for BMC formation whereby shell proteins interact with 306 
an initial aggregate. If the aggregate forms too quickly then the BMC cannot keep pace with 307 
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the aggregate and the BMC does not encapsulate the cargo which results in the formation of 308 
a large inclusion within the cell as seen with P18-fvMT (Figure 5 and Figure A10 (Appendix 309 
1)). However, if enough shell protein is available the shell is able to form around the aggregate 310 
with high flexibility. The extent of fvMT aggregation was differentially influenced by the various 311 
tags. L20 encapsulated fvMT aggregates were smallest, followed by D18, while P18 fvMT 312 
produced largest structures, which was often observed to form un-encapsulated inclusions. 313 
The extent of aggregation caused by the tags seems to be conserved for all experiments, 314 
suggesting that P18 tag causes the largest amount of aggregation, followed by the D18 tag, 315 
whilst L20 tag does not cause large amounts of aggregation, but can still effectively target to 316 
compartments if the protein is able to aggregate by itself, as apparent in the fvMT experiments. 317 
In the absence of any cargo the shell proteins are able to associate together and generate 318 
comparatively small structures.  Overall, the size and shape of BMCs appears to be primarily 319 
dictated by cargo-cargo and shell-cargo interactions, explaining why catabolic BMCs have 320 
such a varied topology as predicted by computational and theoretical modeling (Mohajerani & 321 
Hagan, 2018). 322 
 323 
Experimental Procedures 324 
Molecular biology and bacterial strains 325 
DNA encoding PduL20 was synthesised and cloned into the BglII and NdeI sites of pET14b 326 
(Sequence A1(Appendix 3)). Genomic DNA used for PCR reactions was supplied by DSMZ 327 
(Table A1 (Appendix 2)). Primers (Table A2 (Appendix 2)), plasmids (Table A3 (Appendix 328 
2)) and bacterial strains (Table A4 (Appendix 2)) used are available in the appendix. 329 
Molecular biology was carried out in E. coli JM109 strain, while all other experiments were 330 
carried out in E. coli BL21 Star (DE3) strain. 331 
Growth of strains 332 
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BL21 Star (DE3) competent cells were transformed with appropriate plasmids. LB 333 
supplemented with ampicillin (100 mg/L) and chloramphenicol (34 mg/L) in baffled flasks was 334 
inoculated from an overnight starter culture. Cells were grown at 37 °C with shaking to an 335 
OD600 ∼ 0.4, protein production was induced by addition of IPTG to a final concentration of 336 
400 μM. Cultures were incubated for 4 h (confocal) or overnight at 19 °C with shaking. 337 
TEM analysis 338 
Cells were harvested by centrifugation at 3000 x g for 10 minutes. The cell pellet was 339 
resuspended in 2 mL 2.5% (w/v) glutaraldehyde in 100 mM sodium cacodylate buffer, pH 7.2, 340 
(CAB) and fixed for 2 hours with gentle rotating (20 rpm). Cells were pelleted by centrifugation 341 
at 6000 x g for 2 minutes and were washed twice for 10 minutes with 100 mM CAB. Cells were 342 
post-fixed with 1% (w/v) osmium tetroxide in 100 mM CAB for 2 hours and subsequently 343 
washed twice with ddH2O. Cells were dehydrated by incubation in an ethanol gradient, 50% 344 
EtOH for 10 minutes, 70% EtOH overnight, 90% EtOH for 10 minutes followed by three 10 345 
minute washes in 100% dry EtOH. Cells were then washed twice with propylene oxide for 15 346 
minutes. Cell pellets were embedded by resuspension in 1 mL of a 1:1 mix of propylene oxide 347 
and Agar LV Resin and incubated for 30 minutes with rotation. Cell pellets were infiltrated 348 
twice in 100% Agar LV resin. The cell pellet was re- suspended in fresh resin and transferred 349 
to a 1 mL Beem embedding capsule, centrifuged for 5 minutes at 3000 x g to concentrate the 350 
cells to the tip of the mould and incubated for 20 hours at 60 °C to polymerize. 351 
Samples were ultra-thin sectioned on a RMC MT-XL ultra-microtome with a diamond knife 352 
(diatome 45°). Sections (60 – 70 nm) were collected on un-coated 300 mesh copper grids. 353 
Grids were stained by incubation in 4.5% (w/v) uranyl acetate in 1% (v/v) acetic acid solution 354 
for 45 minutes followed by washing in a stream of ddH2O. Grids were then stained with 355 
Reynolds lead citrate for 7 minutes followed by washing in a stream of ddH2O. 356 
Electron microscopy was performed using a JEOL-1230 transmission electron microscope 357 
equipped with a Gatan multiscan digital camera operated at an accelerating voltage of 80 kV. 358 
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Purification of BMCs 359 
Cells were harvested by centrifugation at 2683 x g. A 1 g wet cell pellet was resuspended in 360 
20 mL Yeast Protein Extraction Reagent (Thermo Scientific) supplemented with Protease 361 
Inhibitor Cocktail Tablets, EDTA-Free (Sigma-Aldrich) and 500 Units Benzonase® Nuclease 362 
(Merck) and incubated for 3 hours at room temperature with gentle shaking. Cell lysate was 363 
pelleted by centrifugation for 5 minutes at 11,300 X g, the pellet was resuspended in 2 mL of 364 
20 mM Tris-HCl, pH 8.0, 20 mM NaCl. The suspension was centrifuged at 4 °C for 5 minutes 365 
at 11,000 X g and the supernatant was collected. The NaCl concentration was increased to 366 
80 mM with 5 M NaCl, this was then centrifuged at 4 °C for 5 minutes at 11,000 X g. The pellet 367 
was resuspended in 1 mL of 20 mM Tris-HCl, pH 8.0, and was clarified by centrifugation at 368 
4°C for 5 minutes at 11,000 X g. The supernatant contain microcompartments was collected 369 
for analysis. 370 
Pyruvate decarboxylase activity assay 371 
Protein purification was carried out as described previously (Lee et al., 2018a). Purified protein 372 
was buffer exchanged using a PD10 column (GE Healthcare) into 50mM Na-phosphate pH 373 
7.0, 5mM MgSO4, 0.1mM thiamine pyrophosphate buffer. Enzyme concentration was 374 
estimated using absorbance at 280nm and diluted to a stock concentration of 0.1 mg/mL. PDC 375 
activity was measured using an alcohol dehydrogenase coupled assay (Gounaris et al., 1971). 376 
Briefly, pyruvate is decarboxylated by PDC leading to the production of acetaldehyde which is 377 
subsequently reduced by alcohol dehydrogenase (ADH) using NADH. The oxidation of NADH 378 
is measured at 340nm and the rate of the reaction is calculated using Michaelis-Menten 379 
equation. Reactions contained 0.15mM NADH, 20U ADH (ADH from S. cerevisiae; Sigma), 380 
1µg PDC, 50µM-10mM Pyruvate, which was added last. All measurements were carried out 381 
at 25oC in 50mM Na-phosphate buffer, pH 7.0, containing 5mM MgSO4 and 0.1mM thiamine 382 
pyrophosphate. 383 
Confocal imaging 384 
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Following growth and induction of protein expression 1 mL of cells was harvested by 385 
centrifugation at 3000 x g. The resulting cell pellet was washed 3 times in PBS before 386 
incubation for 15 minutes in 2% (w/v) formaldehyde in PBS, cells were then washed a further 387 
3 times in PBS. Cells (10 μL) were pipetted onto a 1.5 thickness coverslip before being 388 
inverted onto a drop of ProLong Gold antifade mountant (Life Technologies) on a glass slide 389 
Slides were incubated at room temperature in the dark for 24 hours to cure. 390 
Images were acquired on a Zeiss LSM 880 with Airyscan system. Excitation light (514 nm for 391 
mCitrine or 561 nm for mCherry) was provided by an argon lamp (514nm) or HeNe Laser 392 
(561nm). Images were acquired using a 100x 1.46 NA oil immersion objective lens. 393 
Immuno TEM 394 
Strains were cultured as described previously, cells were harvested by centrifugation for 10 395 
min at 3000 x g. The cell pellet was resuspended in 2% formaldehyde and 0.5% 396 
glutaraldehyde in 100 mM sodium cacodylate, pH 7.2, and incubated for 2 h with gentle 397 
rotating. Cells were pelleted by centrifugation at 6000 x g for 2 min and were washed twice for 398 
10 min with 100 mM sodium cacodylate, pH 7.2. This was followed by dehydration of the 399 
samples in an ethanol gradient, 50% EtOH for 10 min, 70% EtOH for 10 min, 90% EtOH for 400 
10 min, followed by three 15 min washes in 100% EtOH. Cell pellets were then resuspended 401 
in 2 mL LR white resin and incubated overnight with rotation at room temperature after which 402 
the resin was changed and incubated for a further 6 h. Cell pellets were resuspended in fresh 403 
resin and transferred to 1 mL gelatine capsules and centrifuged at 4000 x g to pellet the cells 404 
at the tip. Samples were polymerised at 60 °C for 24 h. Samples were ultra-thin sectioned on 405 
a RMC MT-XL ultramicrotome with a diamond knife (diatome 45°) sections (60–70nm thick) 406 
were collected on 300 mesh gold grids. 407 
Grids were equilibrated in one drop of TBST (20 mM Tris–HCl buffer, pH 7.2, containing 500 408 
mM NaCl, 0.05% Tween 20 and 0.1% BSA) before being transferred into a drop of 2% BSA 409 
in TBST and incubated at room temperature for 30 min. Grids were then immediately 410 
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transferred into a 20 μL drop of relevant primary antibody (rabbit anti- PduA (Parsons et al., 411 
2010) or mouse anti-GFP, for detecting Citrine; Sigma Aldrich) and incubated for 1 h. Grids 412 
were washed in a fresh drop of TBST followed by washing for 10 s in a stream of TBST. Grids 413 
were equilibrated in a drop of relevant secondary antibody (Goat anti-rabbit IgG 10 nm or Goat 414 
anti-mouse IgG 10 nm gold (Agar Scientific)) then incubated for 30 min in a fresh drop. Excess 415 
antibody was removed by washing in two drops of TBST before washing in a stream of ddH2O 416 
and dried. 417 
Grids were stained for 15 minutes in 4.5% uranyl acetate in 1% acetic acid solution followed 418 
by 2 washes in dH2O. Grids were then stained with Reynolds lead citrate for 3 min followed 419 
by a wash in ddH2O. Electron microscopy was performed using a JEOL-1230 transmission 420 
electron microscope equipped with a Gatan multi-scan digital camera at an accelerating 421 
voltage of 80 kV. 422 
Tomography 423 
Sections (250 nm) were cut from the existing blocks as described above. Gold fiducials (15 424 
nm, Aurion, TomoSol solution) were applied to both surfaces of the sections. The sections 425 
were imaged at 200 kV in a Tecnai 20 TEM (FEI, the Netherlands) and double tilt series 426 
images acquired between −67° to +69.5° (first axis) and −66° to +64.5° (second axis) with 1.5° 427 
(above 45°) and 2° increments (below 45°). The pixel size on the 4k by 4k FEI Eagle camera 428 
was 0.74 nm. The resulting tomograms were reconstructed and combined using IMOD 429 
software (Kremer et al., 1996). The isolated microcompartments were segmented manually 430 
using the AMIRA software suite, as shown in Supplementary Video 2. Only structures fully 431 
covered by the tomogram section were analysed. AMIRA software animations were further 432 
used for visualizing and analysing the data. 433 
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Figure 1. Encapsulation of native proteins in recombinant Pdu BMCs. Electron micrographs of 
Escherichia coli cells producing PduD, PduL or PduP in the absence (top panel) and presence (middle 
panel) of a minimal BMC shell system (PduA-U). The BMCs extracted from strains in the middle panel 
are also shown. The control sample contains an empty vector. Arrows indicate areas of protein 
aggregation. All scale bars are 200 nm. 
 
Figure 2. Comparison of the kinetic values of modified PDCs. Encapsulation peptides (D18, L20 and 
P18) were fused to three distinct PDCs. After recombinant production and purification the kinetic 
parameters of the various encapsulation-fused PDCs were measured in terms of Vmax (left scale 
bar) and Km (right scale bar) and expressed as a percentage of the activity of the PDC without the 
encapsulation tag. Light grey bar – Vmax; dark grey bar – KM. Assays were carried out in triplicate; 
error bars equal one standard deviation. 
 
Figure 3. Targeting of fluorescent proteins to recombinant Pdu BMCs. Transmission electron 
micrographs (left two columns) and confocal microscopy (right two columns) images of cells 
expressing differentially tagged Citrine in the presence and absence of mCherry-tagged BMCs (mAU). 
Cells containing the empty pLysS vector are unable to produce BMCs whilst those containing mAU 
within the pLysS vector produce BMCs with an mCherry tag as evidenced by red puncta within the 
cytoplasm. The production of Citrine is visualised by the presence of yellow. Superimposition of red 
and yellow is indicative of localisation. Scale bars in TEM micrographs show 0.2 µm and in confocal 
images 2 µm. 
 
Figure 4. Co-localisation of fluorescent proteins tagged with encapsulation peptides. Confocal 
microscopy was performed on encapsulation peptide-fused fluorescent proteins to determine if the 
encapsulation peptides interact with themselves or each other to co-aggregate. Citrine (yellow) and 
mCherry (red) fluorescent proteins tagged with or without the various encapsulation peptides (D18, 
L20 or P18) were co-produced and imaged as shown. All scale bars are 2 µm. 
 
Figure 5. Production of metallothionein fused to various encapsulation peptides in the presence 
and absence of BMCs. TEM analysis of cells producing metallothionein tagged with the D18, L20 and 
P18 encapsulation peptides in the absence (top row) and presence (second row) of PduA-U BMCs. 
TEM of isolated BMCs from the strains in row 2 are shown in row 3. The bottom row shows TEM 
tomography of sections cells from row 2 - see Supplementary Video 1 for full tomography data. All 
scale bars are 200 nm. 
 
Figure 6. 3D reconstructions of Pdu microcompartments. Traced tomograms of PduA-U (left) and 





Figure A1. Percentage of cells expressing the relevant proteins or an empty vector (control) 
containing intracellular aggregates. Black bars indicate no compartment control, white bars – 
coproduced with PduA-U. Error bars equal one standard deviation between three separate counts of 
a single biological repeat (n≥330). 
 
Figure A2. Electron micrograph of PduD co-expressed with recombinant BMCs (PduA-U). Arrow 
showing aggregation which is phenotypic for misfolded BMCs. Scale bar is 0.2 µm. 
 
Figure A3. Percentage of purified intact BMCs coproduced with the relevant proteins showing 
electron density within the lumen of the compartment indicative of successful targeting. Error bars 
equal one standard deviation between three separate counts of a single biological repeat (n≥440). 
 
Figure A4. Protein sequence alignment of the analysed pyruvate decarboxylases from 
Gluconacetobacter diazotrophicus (Gd.PDC), Zymobacter palmae (Zp.PDC) and Zymomonas mobilis 
(Zm.PDC). Generated using the multalin tool (Corpet, 1988). 
 
Figure A5. Quantification of aggregates observed in cells producing Citrine targeted to BMCs 
(n=150). Black bars indicate no compartment control, while white bars indicate co-production with 
mA-U. Only one count was carried out. 
 
Figure A6. Co-expression of His-tagged mCherry with Citrine tagged with different BMC targeting 
peptides. Scale bars show are 2 µm. 
 
Figure A7. Co-expression of D18-tagged mCherry with Citrine tagged with different BMC targeting 
peptides. Scale bars show are 2 µm. 
 
Figure A8. Co-expression of P18-tagged mCherry with Citrine tagged with different BMC targeting 
peptides. Scale bars show are 2 µm. 
 
Figure A9. Co-expression of L20-tagged mCherry with Citrine tagged with different BMC targeting 
peptides. Scale bars show are 2 µm. 
 
Figure A10. Quantification of aggregates containing facets observed in cells producing fvMT targeted 
to BMCs. Black bars indicate no compartment control, white bars – coproduced with PduA-U. Error 
bars equal one standard deviation between three separate counts of a single biological repeat 
(n≥220). 
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Figure A11. Quantification of overall aggregation observed in cells producing fvMT targeted to 
BMCs. Black bars indicate no compartment control, white bars – coproduced with  
PduA-U. Error bars equal one standard deviation between three separate counts of a single 
biological repeat (n≥435). 
 
Figure A12. Immuno-TEM of targeted fMT constructs produced with or without compartments 
showing the localisation of PduA. First row – cells with no PduA-U; second row – cells with protein 
coproduced with PduA-U. All scale bars are 200 nm. 
 






Table A1. Genomic DNA used in this study 
Organism DSMZ Number 
Gluconacetobacter diazotrophicus DSM-5601 
Zymobacter palmae DSM-10491 
Zymomonas mobilis DSM-424 
 
Table A2. Primers used in this study 










Table A3. Plasmids used in this study 
Plasmid name Description Source 
pET14b Overexpression vector containing N-terminal 
hexahistidine-tag, modified to include an SpeI 
site 5’ of BamHI 
Novagen 
pET14b-D18 Overexpression vector containing an N-
terminal D18 targeting tag followed by a short 
amino acid linker (AMGSS) then a 
hexahistidine-tag 
Lee et al., 2016 
pET14b-L20 Overexpression vector containing an N-
terminal L20 targeting tag (first 20 amino 
acids of PduL from Citrobacter freundii) 
followed by a short amino acid linker (AMGSS) 
then a hexahistidine-tag Synthesised DNA 
sequence shown in Sequence A1 (Appendix 
3). BglII/NdeI ligated into BglII/NdeI site of 
pET14b vector. 
This study 
pET14b-P18 Overexpression vector containing an N-
terminal P18 targeting tag followed by a short 
amino acid linker (PMGSS) then a 
hexahistidine-tag 
Lee et al., 2016 
pLysS Basal expression suppressor  Novagen 
pLysS-PduABJKNU pLysS containing genes required for the 
formation of empty BMCs 
Parsons et al., 2010 
pET3a-pduD pET3a vector containing pduD from 
Citrobacter freundii ligated into NdeI/SpeI site 
Parsons et al., 2010 
pET3a-pduL pET3a vector containing pduL from 
Citrobacter freundii ligated into NdeI/SpeI site 
This study 
pET3a-pduP pET3a vector containing pduP from 
Citrobacter freundii ligated into NdeI/SpeI site 
This study 
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pET3a-mCherryPduABB’JKNU pET3a vector containing genes required for 
the formation of empty BMCs tagged with 
mCherry fluorescent protein 
Parsons et al., 2010 
pET14b.GdPDC PCR product of GdPDC ligated into NdeI/SpeI 
sites of pET14b 
This study 
pET.D18-GdPDC NdeI/SpeI fragment from pET14b.GdPDC 
ligated into NdeI/SpeI site of pET14b-D18 
This study 
pET.L20-GdPDC NdeI/SpeI fragment from pET14b.GdPDC 
ligated into NdeI/SpeI site of pET14b-L20 
This study 
pET.P18-GdPDC NdeI/SpeI fragment from pET14b.GdPDC 
ligated into NdeI/SpeI site of pET14b-P18 
This study 
pET14b.ZmPDC PCR product of ZmPDC ligated into NdeI/SpeI 
sites of pET14b 
This study 
pET.D18-ZmPDC NdeI/SpeI fragment from pET14b.ZmPDC 
ligated into NdeI/SpeI site of pET14b-D18 
This study 
pET.L20-ZmPDC NdeI/SpeI fragment from pET14b.ZmPDC 
ligated into NdeI/SpeI site of pET14b-L20 
This study 
pET.P18-ZmPDC NdeI/SpeI fragment from pET14b.ZmPDC 
ligated into NdeI/SpeI site of pET14b-P18 
This study 
pET14b.ZpPDC PCR product of ZpPDC ligated into NdeI/SpeI 
sites of pET14b 
This study 
pET.D18-ZpPDC NdeI/SpeI fragment from pET14b.ZpPDC 
ligated into NdeI/SpeI site of pET14b-D18 
This study 
pET.L20-ZpPDC NdeI/SpeI fragment from pET14b.ZpPDC 
ligated into NdeI/SpeI site of pET14b-L20 
This study 
pET.P18-ZpPDC NdeI/SpeI fragment from pET14b.ZpPDC 
ligated into NdeI/SpeI site of pET14b-P18 
This study 
pET_CC_Di_A_Citrine Plasmid containing citrine gene in the 
NdeI/SpeI site 
Lee et al., 2018 
pET14b.Citrine NdeI/SpeI fragment from 
pET_CC_Di_A_Citrine ligated into NdeI/SpeI 
site of pET14b 
This study 
pET.D18-Citrine NdeI/SpeI fragment from pET14b.Citrine 
ligated into NdeI/SpeI site of pET14b-D18 
This study 
pET.L20-Citrine NdeI/SpeI fragment from pET14b.Citrine 
ligated into NdeI/SpeI site of pET14b-L20 
This study 
pET.P18-Citrine NdeI/SpeI fragment from pET14b.Citrine 
ligated into NdeI/SpeI site of pET14b-P18 
This study 
pET_CC_Di_A_mCherry Plasmid containing mCherry gene in the 
NdeI/SpeI site 
Lee et al., 2018 
pET14b.mCheery NdeI/SpeI fragment from 
pET_CC_Di_A_mCherry ligated into NdeI/SpeI 
site of pET14b 
This study 
pET.D18-mCheery NdeI/SpeI fragment from pET14b.mCheery 
ligated into NdeI/SpeI site of pET14b-D18 
This study 
pET.L20-mCheery NdeI/SpeI fragment from pET14b.mCheery 
ligated into NdeI/SpeI site of pET14b-L20 
This study 
pET.P18-mCheery NdeI/SpeI fragment from pET14b.mCheery 
ligated into NdeI/SpeI site of pET14b-P18 
This study 
pET14b.fvMT PCR of the coding sequence of fvMT ligated 
into NdeI/SpeI site of pET14b 
This study 
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pET.D18-fvMT NdeI/SpeI fragment from pET14b.fvMT 
ligated into NdeI/SpeI site of pET14b-D18 
This study 
pET.L20-fvMT NdeI/SpeI fragment from pET14b.fvMT 
ligated into NdeI/SpeI site of pET14b-L20 
This study 
pET.P18-fvMT NdeI/SpeI fragment from pET14b.fvMT 




Table A4. Strains used in this study 
Strain Genotype Source 
JM109 endA1, recA1, gyrA96, thi, hsdR17 (rk–, mk+), 
relA1, supE44, Δ(lac-proAB), [F′, traD36, 
proAB, laqIqZΔM15] 
Promega 
BL21 Star (DE3) F– ompT hsdSB (rB– mB–) gal dcm (DE3) Novagen 
 
Appendix 3 
Sequence A1. Synthetic sequence used to construct pET14b-L20 
>L20H 
AGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTG
TTTAACTTTAAGAAGGAGATATCATGGATAAACAGCAACTGGAGACAACGGTCACCAAAGTTCTGGATGAAA
TGCGTGAGCGCGCCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCC
ATATG 
 
 
